Bioprosperity

‘Working for life’




Our corporate IDToday’s Life Sciences industry is being transformed by complex globalized partneringtransactions.BioProsperity founded in 2009 is a life sciences business expert team of 3 managingpartners and 4 Associates that specialize in Marker research, Business analysis andtechnology trasnfer. Our team that provides the industrial and academic sectors ofhealthcare, pharmaceuticals, food technology, cosmeceuticals, bioanalyticaltechnology, agricultural products and biofuels with a new approach to R&D, strategic,marketing consulting and tech transfer services.We offer a comprehensive range of deal advisory services. Our unrivalled bank ofspecialist knowledge, experience and network of contacts within a wide range of LifeSciences sectors make our team uniquely placed to support our client business.Our main principle is that the best advice requires both in-depth scientific andtechnical expertise and a keen appreciation for the critical business and operationalconsiderations.Our experts have proven track records in both strategic planning and execution. Wecontinuously cultivate the ability to crossbreed rigorous understanding of executivelevel business objectives with technician level execution.Our experts carry wide experience in every phase of new product, life cyclemanagement and company development and are totally committed to our clients’success.


Our Vision

We dream of a new prosperous business landscape in South-Eastern Europe focusing on:

innovative Life-Sciences R&D and market creation

intangible asset transformation to prosperous business

successful alliance strategies.


Our MissionWe dynamically map the evolution of our regional Life Sciences academic and private sectors.We develop novel R&D concepts transforming complex bio-scientific data born in South-Eastern Europe to attractive start up, spin out or spin off schemes.We assist our partners in establishing successful sales and marketing networks.We provide cost effective quick assessments based on in-house business plan reviews. We perform a complete evaluation on a specific business area, such as regulatory, operations, budget or IP using in-house and/or on-site reviews. We combine thorough analysis and recommendations which are provided with supporting information.We put our clients at the center of our business operations.We offer complete privacy and confidentiality in our client affairs to ensure the success of each project we undertake.


Our operations in three words


Four core activities

NBD & market launchNBD & market launch

NBD market expansion & NBD market expansion & penetrationpenetration

Due diligence & Due diligence & valuationvaluation

Technology transfer & product valuation


New business development and market launchDesigning a strategy to launch a new product successfully and thenmarket it with maximum returns is a critical task of senior management.

It is especially important for Life Science and healthcare companiesand academics that lack the resources and experience to fully developand launch an innovative product/service in the emerging markets ofSouth Eastern Europe. The latter are characterized by regulatoryvolatility and sociopolitical complexities.

BioProsperity provides expertise in commercialization scenarios thatincorporate regional socioeconomic market trends, different productprofiles, alliance approaches and partnering types to model the mostappropriate strategy for our clients.

Our consulting team carries many years of industry R&D, financialmanagement and commercial experience in our region. This capabilityallows us to accurately identify critical risks and vital opportunities forprofit maximization.


New Business development for market expansion & penetration



Due diligence and valuation


Target assessments for investment

Mergers, acquisitions & alliances

IP Licensing & planning

Strategic partnering

Outsourcing & contracting

Management support

Start-up & interim management

Financial analysis and forecasting


Technology Transfer & Product Valuation


Global patent research

Competitive IP analysis

Technology and product valuation

Competitive technology dynamics

Development of multiple success

scenario

Technobrokershipcontracts

Technology transfer & product

valuation


Paradigms of on-going projects


‘Working for life’‘Working for life’‘Working for life’


www.coringreen.com

www.biotechgreece.com

‘Working for life’21

S/T objectivesTo demonstrate the technology performance in two different case studies in structures located in marine and terrestrial environments.

To demonstrate the environmental value of the developed technology by analyzing the environmental behavior of the two treated structures as case study and their LCA.

To analyze the costs of commercial production of the developed technology within the frame of LCCA

To provide the technical knowledge and recommendations for the use of this kind of coatings in structures to different stakeholders (civil engineers, technological providers, off-site and on-site workers…) through training and education.

To establish the main points of exploitation plan and business model options for exploiting the developed bio-mimetic coating.

To disseminate project results presenting the technology in different congress and international papers.


Work Plan

• WP1: Analysis and selection of the microorganisms to be included in the solgel matrix. WP Leader : INBIOTEC (M1-M12)

• WP2: Analysis of secreted substances that inhibit MIC and biofouling. WP Leader: ACCIONA (M9-M19)

• WP3: Synthesis of a solgel matrix for the metal surface coating where the microorganisms anti-MIC and antifouling will be included. WP Leader : FREIBERG University (M13-M24).

• WP4: Analysis of the environmental aspects of the biomimeticdeveloped coating. WP Leader : GRUPPO CSA (M16-M27)

• WP5: Demonstration. WP Leader : GIRARDI COSTRUZIONI (M25-M42)

• WP6. Dissemination. WP Leader : STRESS (M1-M42)

• WP7: Exploitation and Market evaluation. WP Leader: BIOPROSPERITY (M31-M42)

• WP8: Project management. WP Leader: ACCIONA (M1-M42)


1. Assessment of the expected socio-economic impact ofthe knowledge and the generated technology.

2. Detailed market study and evaluation of market potential.

3. New business models to demonstrate project’sfeasibility and market potential.

4. Methodology and strategy for a proper management ofthe generated knowledge and intellectual propertyprotection.

5. Identification of socio-economical, technical and legalbarriers at European level that could limit theexploitation.

WP 7 TasksExploitation and Market evaluation

WP Leader : BIOPROSPERITY (M31-M42)


Key points to be addressed

• The viability of the microorganisms in the coating, how they will act and how long they will be viable needs to be considered in more depth.

• An important part of Milestone M1 must already be known and WP3 seems late starting since it is a key one.

• An additional testing location belonging to a colder region of Europe should be also selected, as more representative for the European climate.

• The proposal should add business plan elements to demonstrate the feasibility and market potential.

• Barriers that could limit the exploitation should be identified

24


Adding business plan elements to our proposal…

branding, identity, positioning, placement and forecasting……

Marketing… marketing.. Marketing..• Seeking letter of intents from market players and potential buyers around Europe, Asia and America.• identify early the key products and services derived and position them in the market• clear 3 year business plan and financial figures

Bioprosperity

Business

business operations

critical business

client business

lifenew business development

specific business area

innovative lifesciences

inhouse business plan

market launchdesigning